{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:29:57Z","timestamp":1767842997384,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T00:00:00Z","timestamp":1208217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s10067-008-0886-0","type":"journal-article","created":{"date-parts":[[2008,4,14]],"date-time":"2008-04-14T11:21:29Z","timestamp":1208172089000},"page":"1153-1158","source":"Crossref","is-referenced-by-count":13,"title":["Serum levels of natriuretic peptides in patients with Behcet\u2019s disease"],"prefix":"10.1007","volume":"27","author":[{"given":"Ramazan","family":"Ya\u011fc\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u00fcksel","family":"Totan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekin","family":"\u00d6zl\u00fck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcseyin","family":"\u00d6zyurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fclfer","family":"Akbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Ek\u015fio\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,15]]},"reference":[{"key":"886_CR1","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/rheumatology\/38.12.1171","volume":"38","author":"CG Barnes","year":"1999","unstructured":"Barnes CG, Yazici H (1999) Behcet\u2019s syndrome. Rheumatology (Oxford) 38:1171\u20131174","journal-title":"Rheumatology (Oxford)"},{"key":"886_CR2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archopht.125.2.246","volume":"125","author":"K Nakao","year":"2007","unstructured":"Nakao K, Isashiki Y, Sonoda S et al (2007) Nitric oxide synthase and superoxide dismutase gene polymorphisms in Behcet disease. Arch Ophthalmol 125:246\u2013251","journal-title":"Arch Ophthalmol"},{"key":"886_CR3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N et al (1999) Behcet\u2019s disease. N Engl J Med 341:1284\u20131291","journal-title":"N Engl J Med"},{"key":"886_CR4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00002281-200101000-00004","volume":"13","author":"H Yazici","year":"2001","unstructured":"Yazici H, Yurdakul S, Hamuryudan V (2001) Behcet disease. Curr Opin Rheumatol 13:18\u201322","journal-title":"Curr Opin Rheumatol"},{"key":"886_CR5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1046\/j.1365-4362.2003.01688.x","volume":"42","author":"M Cekmen","year":"2003","unstructured":"Cekmen M, Evereklioglu C, Er H et al (2003) Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behcet\u2019s syndrome. Int J Dermatol 42:870\u2013875","journal-title":"Int J Dermatol"},{"key":"886_CR6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bjo.86.6.653","volume":"86","author":"H Er","year":"2002","unstructured":"Er H, Evereklioglu C, Cumurcu T et al (2002) Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet\u2019s disease. Br J Ophthalmol 86:653\u2013657","journal-title":"Br J Ophthalmol"},{"key":"886_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.thromres.2006.02.008","volume":"119","author":"H Yapislar","year":"2007","unstructured":"Yapislar H, Aydogan S, Borlu M et al (2007) Decreased nitric oxide and increased platelet aggregation levels in patients with Behcet\u2019s disease. Thromb Res 119:461\u2013465","journal-title":"Thromb Res"},{"key":"886_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00395-004-0459-6","volume":"99","author":"A Ahluwalia","year":"2004","unstructured":"Ahluwalia A, MacAllister RJ, Hobbs AJ (2004) Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms. Basic Res Cardiol 99:83\u201389","journal-title":"Basic Res Cardiol"},{"key":"886_CR9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","volume":"350","author":"TJ Wang","year":"2004","unstructured":"Wang TJ, Larson MG, Levy D et al (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655\u2013663","journal-title":"N Engl J Med"},{"key":"886_CR10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1538-7836.2005.01752.x","volume":"4","author":"M Sohne","year":"2006","unstructured":"Sohne M, Ten Wolde M, Boomsma F et al (2006) Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism. J Thromb Haemost 4:552\u2013556","journal-title":"J Thromb Haemost"},{"key":"886_CR11","first-page":"261","volume":"3","author":"H Akar","year":"2003","unstructured":"Akar H, Konuralp C, Akpolat T (2003) Cardiovascular involvement in Behcet\u2019s disease. Anadolu Kardiyol Derg 3:261\u2013265","journal-title":"Anadolu Kardiyol Derg"},{"key":"886_CR12","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s D","year":"1990","unstructured":"International Study Group for Behcet\u2019s D (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"886_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","volume":"43","author":"G Lawton","year":"2004","unstructured":"Lawton G, Bhakta BB, Chamberlain MA et al (2004) The Behcet\u2019s disease activity index. Rheumatology (Oxford) 43:73\u201378","journal-title":"Rheumatology (Oxford)"},{"key":"886_CR14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/rheumatology\/38.8.734","volume":"38","author":"V Hamuryudan","year":"1999","unstructured":"Hamuryudan V, Fresko I, Direskeneli H et al (1999) Evaluation of the Turkish translation of a disease activity form for Behcet\u2019s syndrome. Rheumatology (Oxford) 38:734\u2013736","journal-title":"Rheumatology (Oxford)"},{"key":"886_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0022-1759(92)90061-W","volume":"150","author":"T Porstmann","year":"1992","unstructured":"Porstmann T, Kiessig ST (1992) Enzyme immunoassay techniques. An overview. J Immunol Methods 150:5\u201321","journal-title":"J Immunol Methods"},{"key":"886_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0022-1759(92)90062-X","volume":"150","author":"S Avrameas","year":"1992","unstructured":"Avrameas S (1992) Amplification systems in immunoenzymatic techniques. J Immunol Methods 150:23\u201332","journal-title":"J Immunol Methods"},{"key":"886_CR17","doi-asserted-by":"crossref","first-page":"R1133","DOI":"10.1186\/ar1798","volume":"7","author":"Y Lu","year":"2005","unstructured":"Lu Y, Ye P, Chen SL et al (2005) Identification of kinectin as a novel Behcet\u2019s disease autoantigen. Arthritis Res Ther 7:R1133\u2013R1139","journal-title":"Arthritis Res Ther"},{"key":"886_CR18","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/art.20189","volume":"50","author":"Y Xiang","year":"2004","unstructured":"Xiang Y, Sekine T, Nakamura H et al (2004) Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum 50:1511\u20131521","journal-title":"Arthritis Rheum"},{"key":"886_CR19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.exer.2007.01.003","volume":"84","author":"Y Okunuki","year":"2007","unstructured":"Okunuki Y, Usui Y, Takeuchi M et al (2007) Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet\u2019s disease. Exp Eye Res 84:823\u2013831","journal-title":"Exp Eye Res"},{"key":"886_CR20","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.11074","volume":"48","author":"KH Lee","year":"2003","unstructured":"Lee KH, Chung HS, Kim HS et al (2003) Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet\u2019s disease. Arthritis Rheum 48:2025\u20132035","journal-title":"Arthritis Rheum"},{"key":"886_CR21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000051544","volume":"201","author":"C Evereklioglu","year":"2000","unstructured":"Evereklioglu C, Yurekli M, Er H et al (2000) Increased plasma adrenomedullin levels in patients with Behcet\u2019s disease. Dermatology 201:312\u2013315","journal-title":"Dermatology"},{"key":"886_CR22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2004.06003.x","volume":"151","author":"C Yazici","year":"2004","unstructured":"Yazici C, Kose K, Calis M et al (2004) Increased advanced oxidation protein products in Behcet\u2019s disease: a new activity marker? Br J Dermatol 151:105\u2013111","journal-title":"Br J Dermatol"},{"key":"886_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1620\/tjem.212.133","volume":"212","author":"A Isik","year":"2007","unstructured":"Isik A, Koca SS, Ustundag B et al (2007) Decreased total antioxidant response and increased oxidative stress in Behcet\u2019s disease. Tohoku J Exp Med 212:133\u2013141","journal-title":"Tohoku J Exp Med"},{"key":"886_CR24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s10067-006-0513-x","volume":"26","author":"S Taysi","year":"2007","unstructured":"Taysi S, Demircan B, Akdeniz N et al (2007) Oxidant\/antioxidant status in men with Behcet\u2019s disease. Clin Rheumatol 26:418\u2013422","journal-title":"Clin Rheumatol"},{"key":"886_CR25","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00296-006-0126-3","volume":"26","author":"A Sepici-Dincel","year":"2006","unstructured":"Sepici-Dincel A, Ozkan Y, Yardim-Akaydin S et al (2006) The association between total antioxidant status and oxidative stress in Behcet\u2019s disease. Rheumat Int 26:1005\u20131009","journal-title":"Rheumat Int"},{"key":"886_CR26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1468-3083.2005.01075.x","volume":"19","author":"S Bekpinar","year":"2005","unstructured":"Bekpinar S, Kilic N, Unlucerci Y et al (2005) Evaluation of nitrosative and oxidative stress in Behcet disease. J Eur Acad Dermatol Venereol 19:167\u2013171","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 3","key":"886_CR27","first-page":"iii68","volume":"60","author":"AK Kiemer","year":"2001","unstructured":"Kiemer AK, Vollmar AM (2001) The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages. Ann Rheum Dis 60(Suppl 3):iii68\u201370","journal-title":"Ann Rheum Dis"},{"key":"886_CR28","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.peptides.2004.08.034","volume":"26","author":"AM Vollmar","year":"2005","unstructured":"Vollmar AM (2005) The role of atrial natriuretic peptide in the immune system. Peptides 26:1086\u20131094","journal-title":"Peptides"},{"key":"886_CR29","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1074\/jbc.273.22.13444","volume":"273","author":"AK Kiemer","year":"1998","unstructured":"Kiemer AK, Vollmar AM (1998) Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J Biol Chem 273:13444\u201313451","journal-title":"J Biol Chem"},{"key":"886_CR30","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1097\/00003246-199511000-00017","volume":"23","author":"K Aiura","year":"1995","unstructured":"Aiura K, Ueda M, Endo M et al (1995) Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat. Crit Care Med 23:1898\u20131906","journal-title":"Crit Care Med"},{"key":"886_CR31","first-page":"191","volume":"46","author":"BP Roques","year":"1998","unstructured":"Roques BP (1998) Cell surface metallopeptidases involved in blood pressure regulation: structure, inhibition and clinical perspectives. Pathol Biol (Paris) 46:191\u2013200","journal-title":"Pathol Biol (Paris)"},{"key":"886_CR32","first-page":"609","volume":"41","author":"JM Soleilhac","year":"1992","unstructured":"Soleilhac JM, Lucas E, Beaumont A et al (1992) A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium. Mol Pharmacol 41:609\u2013614","journal-title":"Mol Pharmacol"},{"key":"886_CR33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.2823385","volume":"238","author":"T Maack","year":"1987","unstructured":"Maack T, Suzuki M, Almeida FA et al (1987) Physiological role of silent receptors of atrial natriuretic factor. Science 238:675\u2013678","journal-title":"Science"},{"key":"886_CR34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1146\/annurev.ph.54.030192.000303","volume":"54","author":"T Maack","year":"1992","unstructured":"Maack T (1992) Receptors of atrial natriuretic factor. Annu Rev Physiol 54:11\u201327","journal-title":"Annu Rev Physiol"},{"key":"886_CR35","first-page":"S19","volume":"19","author":"E Eksioglu-Demiralp","year":"2001","unstructured":"Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A et al (2001) Neutrophil activation in Behcet\u2019s disease. Clin Exp Rheumatol 19:S19\u201324","journal-title":"Clin Exp Rheumatol"},{"key":"886_CR36","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4065\/80.8.1029","volume":"80","author":"PM McKie","year":"2005","unstructured":"McKie PM, Burnett JC Jr (2005) B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities. Mayo Clin Proc 80:1029\u20131036","journal-title":"Mayo Clin Proc"},{"key":"886_CR37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/heart.87.2.131","volume":"87","author":"M Nakamura","year":"2002","unstructured":"Nakamura M, Endo H, Nasu M et al (2002) Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart 87:131\u2013135","journal-title":"Heart"},{"key":"886_CR38","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.rmed.2005.02.029","volume":"99","author":"DG Kiely","year":"2005","unstructured":"Kiely DG, Kennedy NS, Pirzada O et al (2005) Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Respir Med 99:1286\u20131291","journal-title":"Respir Med"},{"key":"886_CR39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pharmthera.2004.08.011","volume":"105","author":"RS Scotland","year":"2005","unstructured":"Scotland RS, Ahluwalia A, Hobbs AJ (2005) C-type natriuretic peptide in vascular physiology and disease. Pharmacol Ther 105:85\u201393","journal-title":"Pharmacol Ther"},{"key":"886_CR40","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0735-1097(96)00241-0","volume":"28","author":"RS Wright","year":"1996","unstructured":"Wright RS, Wei CM, Kim CH et al (1996) C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems. J Am Coll Cardiol 28:1031\u20131038","journal-title":"J Am Coll Cardiol"},{"key":"886_CR41","doi-asserted-by":"crossref","first-page":"H1151","DOI":"10.1152\/ajpheart.2001.280.3.H1151","volume":"280","author":"MB Hussain","year":"2001","unstructured":"Hussain MB, MacAllister RJ, Hobbs AJ (2001) Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases. Am J Physiol Heart Circ Physiol 280:H1151\u20131159","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"886_CR42","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/sj.bjp.0705365","volume":"139","author":"M Madhani","year":"2003","unstructured":"Madhani M, Scotland RS, MacAllister RJ et al (2003) Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br J Pharmacol 139:1289\u20131296","journal-title":"Br J Pharmacol"},{"key":"886_CR43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000018061","volume":"198","author":"A Orem","year":"1999","unstructured":"Orem A, Vanizor B, Cimsit G et al (1999) Decreased nitric oxide production in patients with Behcet\u2019s disease. Dermatology 198:33\u201336","journal-title":"Dermatology"},{"key":"886_CR44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000055641","volume":"33","author":"GE Mirza","year":"2001","unstructured":"Mirza GE, Karakucuk S, Er M et al (2001) Tear nitrite and nitrate levels as nitric oxide end products in patients with Behcet\u2019s disease and non-Behcet\u2019s uveitis. Ophthalmic Res 33:48\u201351","journal-title":"Ophthalmic Res"},{"key":"886_CR45","first-page":"449","volume":"36","author":"M Sahin","year":"2006","unstructured":"Sahin M, Arslan C, Naziroglu M et al (2006) Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet\u2019s disease. Ann Clin Lab Sci 36:449\u2013454","journal-title":"Ann Clin Lab Sci"},{"key":"886_CR46","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2133.2005.06543.x","volume":"153","author":"S Buldanlioglu","year":"2005","unstructured":"Buldanlioglu S, Turkmen S, Ayabakan HB et al (2005) Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet\u2019s disease. Br J Dermatol 153:526\u2013530","journal-title":"Br J Dermatol"},{"key":"886_CR47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/CCLM.2007.018","volume":"45","author":"Y Ozkan","year":"2007","unstructured":"Ozkan Y, Yardim-Akaydin S, Sepici A et al (2007) Assessment of homocysteine, neopterin and nitric oxide levels in Behcet\u2019s disease. Clin Chem Lab Med 45:73\u201377","journal-title":"Clin Chem Lab Med"},{"key":"886_CR48","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.biocel.2003.09.009","volume":"36","author":"SD Chauhan","year":"2004","unstructured":"Chauhan SD, Hobbs AJ, Ahluwalia A (2004) C-type natriuretic peptide: new candidate for endothelium-derived hyperpolarising factor. Int J Biochem Cell Biol 36:1878\u20131881","journal-title":"Int J Biochem Cell Biol"},{"key":"886_CR49","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/01.CIR.0000014985.50017.6E","volume":"105","author":"N Ohno","year":"2002","unstructured":"Ohno N, Itoh H, Ikeda T et al (2002) Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation 105:1623\u20131626","journal-title":"Circulation"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-0886-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-008-0886-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-0886-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:13Z","timestamp":1559119873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-008-0886-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,15]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["886"],"URL":"https:\/\/doi.org\/10.1007\/s10067-008-0886-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,15]]}}}